Medicine and Dentistry
Woman
100%
Therapeutic Procedure
80%
Endometriosis
74%
Progesterone Receptor Modulator
53%
Randomized Controlled Trial
49%
Endometrium
36%
Pain
32%
Symptom
29%
Gynecology
22%
Uterine Fibroid
21%
Menorrhagia
21%
Quality of Life
20%
Low Drug Dose
20%
Arm
18%
Clinical Trial
18%
Ulipristal
18%
Dexamethasone
17%
Group Trial
17%
Progesterone Receptor
17%
COVID-19
17%
Adaptive Response
17%
Neuropathic Pain
17%
Inpatient
17%
Dichloroacetic Acid
17%
Obstetrics
17%
Reproductive Public Health
17%
Symptom Management
17%
Patient
14%
Laparoscopy
14%
Clinical Research
10%
Diagnostics
9%
Diagnosis
9%
Combination Therapy
9%
Bleeding
8%
Chronic Disorder
8%
Pelvic Pain
8%
Surgery
8%
Health
7%
Cell Proliferation
7%
Tissues
7%
Hospital
6%
Quantitative Sensory Testing
6%
Side Effect
6%
Progesterone
5%
Steroid Receptor
5%
Leuprorelin
5%
Adverse Event
5%
Pharmacology, Toxicology and Pharmaceutical Science
Progesterone Receptor Modulator
53%
Menorrhagia
39%
Ulipristal
36%
Placebo
26%
Uterus Myoma
23%
Progesterone Receptor
17%
Dexamethasone
17%
Levonorgestrel
17%
Endometriosis
17%
Symptom
17%
Bleeding
12%
Symptom
9%
Cell Proliferation
7%
Disease
5%
Progesterone
5%
Steroid Receptor
5%
Leuprorelin
5%
Adverse Event
5%
Nursing and Health Professions
Progesterone Receptor Modulator
17%
Uterus Myoma
17%
Pelvis Pain Syndrome
17%
Woman
17%
Endometriosis
17%
Symptom Management
17%
Symptom
17%
Quality of Life
13%
Disease
8%
Imaging
8%
Symptom
7%
Confidence Interval
6%
Laparoscopy
5%
Leuprorelin
5%